BENITIONSClinical Trial Intelligence

A Sugar-Sweetened Beverage Reduction Intervention for Native American Men

不适用 已完成 NCT06029517

适应症Cardiovascular Disorder, Coronary Artery Disease, Diabetes Mellitus, Obesity-Related Malignant Neoplasm
分期不适用
申办方Roswell Park Cancer Institute
状态已完成
受试者人数48 人
干预(药物)Education Intervention, Observation of Indigenous SIPin Interventon, Discussion
开始日期2022年7月20日
完成日期2025年9月15日
结果公布日2026年7月28日

摘要

This clinical trial develops and tests a culturally-appropriate educational program (Indigenous SIPin) for reducing sugar-sweetened beverage consumption in men affiliated with Native American athletics communities. Sugary drinks are drinks like pop, soda, and juice. Increased sugar consumption may lead to an increased risk of chronic diseases, including obesity, diabetes, some types of obesity-related cancers, coronary heart disease, hypertension, and dental decay. A culturally sensitive program may help reduce sugar-sweetened beverage consumption in Native American men

Change in SSB Intake for Men Affiliated With Native American Athletic Communities

up to 6 months · kcal per day

Arm 1 - Indigenous SIPin0.18 ± 87.31 kcal per day

在 BENITIONS 中查看 查看 ClinicalTrials.gov 原文

同一适应症的其他试验

全部试验

本页整理自 ClinicalTrials.gov 的公开数据,不构成医疗建议,也不构成投资建议。请务必咨询专业医师。